Pipeline 2010

The report captures the latest trends, profiling 15 agents with a high probability of reaching market and bright commercial prospects. Surveying today's drug-development scene, the report highlights the rare disease and infectious disease categories, along with stalwarts cardiovascular, metabolic and rheumatology. A final category keeps readers updated on neurology, women's health, respiratory and oncology product candidates.

Descargar...